Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more
US FDA approves second indication for Skyrizi to treat adults with active psoriatic arthritis Read more
Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients Read more
Pfizer’s Prevnar 20 with Pfizer-BioNTech COVID-19 vaccine shows positive results in phase-III study Read more
Experimental Lilly drug neutralises Omicron in lab; slightly higher risk of diabetes seen in kids after COVID Read more
US FDA approves Takeda’s Livtencity to treat people with post-transplant Cytomegalovirus infection Read more